Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

bioAffinity Technologies (BIAF) Interest Expenses (2022 - 2025)

Historic Interest Expenses for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to $5358.0.

  • bioAffinity Technologies' Interest Expenses fell 7523.0% to $5358.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $528931.0, marking a year-over-year increase of 50480.36%. This contributed to the annual value of $92475.0 for FY2024, which is 14909.09% up from last year.
  • Latest data reveals that bioAffinity Technologies reported Interest Expenses of $5358.0 as of Q3 2025, which was down 7523.0% from $483043.0 recorded in Q2 2025.
  • bioAffinity Technologies' Interest Expenses' 5-year high stood at $896502.0 during Q3 2022, with a 5-year trough of $1360.0 in Q2 2023.
  • Over the past 4 years, bioAffinity Technologies' median Interest Expenses value was $21940.0 (recorded in 2024), while the average stood at $144397.0.
  • In the last 5 years, bioAffinity Technologies' Interest Expenses crashed by 9965.94% in 2023 and then surged by 207107.74% in 2025.
  • bioAffinity Technologies' Interest Expenses (Quarter) stood at $89290.0 in 2022, then plummeted by 77.57% to $20025.0 in 2023, then grew by 25.07% to $25045.0 in 2024, then crashed by 78.61% to $5358.0 in 2025.
  • Its Interest Expenses was $5358.0 in Q3 2025, compared to $483043.0 in Q2 2025 and $15485.0 in Q1 2025.